Immune to Cancer: The CRI Blog
-
CRI Funded Scientist
Hyung Jun Kim, PhD
While modern immunotherapies have revolutionized treatment for certain cancers, they remain largely ineffective against solid tumors such… -
CRI Funded Scientist
Joseph Kern, PhD
One of the major challenges in cancer biology is understanding how tumors escape detection by the immune… -
CRI Funded Scientist
Fubo Ji, PhD
Immunotherapy has transformed cancer treatment by harnessing the body’s own immune system to destroy tumors. Yet most… -
CRI Funded Scientist
Zhouping Hong, PhD
The innate immune system serves as the body’s first line of defense against infection and injury, relying… -
CRI Funded Scientist
Ron Gejman, MD, PhD
Organ transplant recipients must take lifelong immunosuppressive drugs to prevent rejection of their transplanted organ. While lifesaving,… -
CRI Funded Scientist
Xueyang Dong, PhD
The immune system’s T cells play a central role in recognizing and eliminating cancer, yet how they… -
CRI Funded Scientist
Maria Cardenas Conti, PhD
Immunotherapy has revolutionized cancer treatment, yet many patients still do not achieve lasting benefit. Among the key… -
CRI Funded Scientist
Emmanuela Adjei-Sowah, PhD
Clear cell renal cell carcinoma (ccRCC) is one of the most common and deadly forms of kidney… -
CRI Funded Scientist
Rachael Safyan, MD
Pancreatic cancer is one of the most aggressive and deadly cancers, with less than 15% of patients…

Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.